Addit: Two placebo studies using spinal cord stimulation (SCS)
were brought to my attention by an attendee at a neuromodulation conference I
was speaking at a few days ago. None of the proponents of SCS included these
papers in their talks and the spine study was not included in the systematic
review I refer to in my previous
blog. And read on, I found a third placebo study.
A study from 2017 (Kriek, 2017)
used five different ‘modes’ of stimulation (different frequencies and patterns)
and placebo allocated at random for two weeks each over a ten week period in
patients with chronic regional pain syndrome. The placebo group did worse. Interestingly,
there was little difference between all the other modes (except burst therapy
did worse), and the difference to placebo was pretty close to the difference
that most people would consider ‘clinically important’. This gives us some
evidence for spinal cord stimulation, but I would have liked to have seen if
the patients were truly blinded. This ‘old’ technology relies on the patient
being able to feel it, and the authors didn’t report on the success of
blinding. I also would have liked to have seen a bigger difference, and authors
that were not paid by the manufacturer, including a professional medical writer
who wrote the article (no serious academic would ever agree to this).
In 2014, researchers published a study (Schu, 2014)randomising
20 patients with ‘failed back surgery syndrome’ to different modes of SCS and
placebo, each over a three week period. This one did not rely on the patient feeling
the stimulation so blinding was probably better, and this was for spine pain,
not chronic regional pain syndrome. Also, although some authors were paid by
the manufacturer and the study was funded by the manufacturer, the study was
conducted independently. The study didn’t show a big (or significant) difference
between placebo and higher frequency stimulation for pain or disability but it
did show that ‘burst’ frequencies did much better than the other groups.
So we have some mixed evidence, with burst therapy either
being the best or the worst of the modes of therapy, and no difference between
higher frequency stimulation and placebo for failed back surgery syndrome.
But while researching these articles, I came across the
study I had always wanted to do: in a study from 2013 (Perruchoud,
2013) newer (high frequency) SCS was compared to sham in a group of 40
patients, who each received both, but were blinded as to which one they got. It
was funded by the manufacturer but they weren’t involved in design, data
collection or writing. This study showed no difference between SCS and sham for
any outcome. That doesn’t surprise me, what does surprise me is that I have
been asking the SCS community to do a trial like this for ages and no one has
ever mentioned it or apparently even been aware of it. I checked the systematic
review again from my previous
post and it WAS listed in there, as a low quality study in which patients
were not blinded, which is not true (but explains why I didn’t look it up). What
the hell is going on here? In other fields where placebo trials have been done
not everyone agrees with the results, but EVERYONE is at least aware of the
studies!
The bottom line
These trials are enough evidence that SCS doesn’t work (particularly
on the back of the much lauded study that high frequency – which is no better
than placebo in 2/2 trials – is superior to conventional). If people want SCS
funded, they should step up and produce studies like these that show an effect.
The problem is, it already is funded.
Great post. It reminds me of Bernard Lown's quote-
ReplyDelete"Doctor as scientist, healer, magician, business entrepreneur, small shopkeeper, or assembly line worker — which is it?"
Could we have a little more scientist and healer and a little less business entrepreneur?
Unfortunately corporate medicine tends toward the equity risk premium and the capital asset pricing model.
When the proceduralist or surgeon has been turned into the commissioned salesperson for big business interests patients and society as a whole lose.